S100A4 promotes squamous cell laryngeal cancer Hep-2 cell invasion via NF-kB/MMP-9 signal

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 9, 2014, Pages 1361-1367

  Zhang, W ^a   Liu, Y ^a   Wang, C W ^a  

^a Department of Radiotherapy Linyi Cancer Institute Hospital   (China)

Author keywords

Invasion; Laryngeal squamous carcinoma; MMP 9; Nuclear factor kB; S10044

Indexed keywords

BATIMASTAT; CALVASCULIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; MATRIX METALLOPROTEINASE INHIBITOR; MMP9 PROTEIN, HUMAN; PROTEIN S 100; RELA PROTEIN, HUMAN; S100A4 PROTEIN, HUMAN;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA TRANSFECTION; ENZYME ACTIVATION; HEP 2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LARYNX SQUAMOUS CELL CARCINOMA; METASTASIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING; CELL MOTION; DRUG EFFECTS; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; LARYNX TUMOR; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR INVASION;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; LARYNGEAL NEOPLASMS; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; NEOPLASM INVASIVENESS; RNA INTERFERENCE; S100 PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 84902174063     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. KARATZANIS AD, PSYCHOGIOS G, ZENK J, WALDFAHRER F, HORNUNG J, VELEGRAKIS GA Comparison among di-Verent available surgical approaches in T1 glottic cancer. Laryngoscope 2009; 119: 1704-1708.
2. COSETTI M, YU G P, SCHANTZ S P. Five-year survival rates and time trends of laryngeal cancer in the US population. Arch Otolaryngol Head Neck Surg 2008; 134: 370-379. (Pubitemid 351581084)
3. CAO CM, YANG FX, WANG PL, YANG QX, SUN XR Clinicopathologic significance of S100A4 expression in osteosarcoma. Eur Rev Med Pharmacol Sci 2014; 18: 833-839.
4. LIU Z, LIU H, PAN H, DU Q, LIANG J. Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma. J Int Med Res 2013; 41: 457-462.
5. LI HJ, CHEN YX, WANG Q, ZHANG YG S100A4 mR-NA as a prognostic marker and therapeutic target in Wilms tumor (WT). Eur Rev Med Pharmacol Sci 2014; 18: 817-827.
6. RUDLAND PS, PLATT-HIGGINS A, RENSHAW C, WEST CR, WINSTANLEY JH, ROBERTSON L, BARRACLOUGH R. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 2000; 60: 1595-1603. (Pubitemid 30183430)
7. GONGOLL S, PETERS G, MENGEL M, PISO P, KLEMPNAUER J, KREIPE H, VON WASIELEWSKI R. Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 2002; 123: 1478-1484. (Pubitemid 35231647)
8. GARRETT SC, VARNEY KM, WEBER DJ, BRESNICK AR S100A4, a mediator of metastasis. J Biol Chem 2006; 281: 677-680.
9. SHERBET GV. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett 2009; 280: 15-30.
10. EBRALIDZE A, TULCHINSKY E, GRIGORIAN M, AFANASYEVA A, SENIN V, REVAZOVA E, LUKANIDIN E. Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family. Genes Dev 1989; 3: 1086-1093.
11. DAVIES BR, DAVIES M P, GIBBS FE, BARRACLOUGH R, RUDLAND PS Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calciumbinding protein, but not with the oncogene EJ-ras-1. Oncogene 1993; 8: 999-1008. (Pubitemid 23087433)
12. GRIGORIAN M, AMBARTSUMIAN N, LYKKESFELDT AE, BASTHOLM L, ELLING F, GEORGIEV G, LUKANIDIN E. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int J Cancer 1996; 67: 831-841. (Pubitemid 26348813)
13. MAELANDSMO GM, HOVIG E, SKREDE M, ENGEBRAATEN O, FLORENES VA, MYKLEBOST O, GRIGORIAN M, LUKANIDIN E, SCANLON KJ, FODSTAD O. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res 1996; 56: 5490-5498. (Pubitemid 27011385)
14. TAKENAGA K, NAKAMURA Y, SAKIYAMA S. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene 1997; 14: 331-337. (Pubitemid 27073088)
15. LEVETT D, FLECKNELL PA, RUDLAND PS, BARRACLOUGH R, NEAL DE, MELLON JK, DAVIES BR Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer. Am J Pathol 2002; 160: 693-700. (Pubitemid 34160347)
16. STEIN U, ARLT F, WALTHER W, SMITH J, WALDMAN T, HARRIS ED, MERTINS SD, HEIZMANN CW, ALLARD D, BIRCHMEIER W, SCHLAG PM, SHOEMAKER RH. The metastasis-associated gene S100A4 is a novel target of -catenin/T-cell factor signaling in colon cancer. Gastroenterology 2006; 131: 1486-1500. (Pubitemid 44708942)
17. CAO WH, LIU HM, LIU X, LI JG, LIANG J, LIU M, NIU ZH Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling. Eur Rev Med Pharmacol Sci 2013; 17: 609-617.
18. JIA W, GAO XJ, ZHANG ZD, YANG ZX, ZHANG G. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF. Eur Rev Med Pharmacol Sci 2013; 17: 1495-1508.
19. YANG XC, WANG X, LUO L, DONG DH, YU QC, WANG XS, ZHAO K. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway. Eur Rev Med Pharmacol Sci 2013; 17: 1669-1680.
20. ZHANG J, ZHANG DL, JIAO XL, DONG Q. S100A4 regulates migration and invasion in HepG2 cells via NF-B-dependent MMP-9 signal. Eur Rev Med Pharmacol Sci 2013; 17: 2372-2382.
21. LIU J, XU ZM, QIU GB, ZHENG ZH, SUN KL, FU WN S100A4 is upregulated via the binding of c-Myb in methylation-free laryngeal cancer cells. Oncol Rep 2014; 31: 442-449.
22. BARTLETT RS, HECKMAN WW, ISENBERG J, THIBEAULT SL, DAILEY SH Genetic characterization of vocal fold lesions: leukoplakia and carcinoma. Laryngoscope 2012; 122: 336-342.
23. LIU J, GUO Y, FU S, YANG M, SUN KL, FU WN Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma. Oncol Rep 2010; 23: 1101-1107.
24. LI G, LIU D, ZHANG Y, QIAN Y, ZHANG H, GUO S, SUNAGAWA M, HISAMITSU T, LIU Y. Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4/NF-κB- mediated matrix metalloproteinase-9 expression. PLoS One 2013; 8: e68905.
25. GROTTERØD I, MAELANDSMO GM, BOYE K. Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB. BMC Cancer 2010; 10: 241.